Skip to main content
Log in

Effect of age on the disposition of sodium fluoride

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Sodium fluoride (NaF) is used in the treatment of axial osteoporosis and so is mostly given to old patients. Since its pharmacokinetics has not been studied in the elderly, the pharmacokinetics of an enteric-coated tablet containing 50 mg NaF has been investigated in 15 aged inpatients (aged 65 to 75 y) and 12 young healthy volunteers (aged 21 to 26 y).

The serum AUC of fluoride was 1.7-time higher in older than in younger subjects. There was a strong inverse correlation between the AUC and either body surface area (BSA) or glomerular filtration rate (GFR), both of which were very much lower in the elderly.

This concluded that if efficacy or safety are related to the bioavailability of fluoride, it maybe valuable to adjust the dosage of fluoride accordingly to the GFR and BSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rich C, Ensink J (1961) Effect of sodium fluoride on calcium metabolism of human beings. Nature 191: 184–185

    CAS  PubMed  Google Scholar 

  2. Hodsman AB, Drost DJ (1989) The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride. J Clin Endocrinol Metab 69: 932–938

    CAS  PubMed  Google Scholar 

  3. Ekstrand J, Alvan G, Boreus LO, Norlin A (1977) Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol 12: 311–317

    Article  CAS  PubMed  Google Scholar 

  4. Ekstrand J, Ehrnebo M, Boreus LO (1978) Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin Pharmacol Ther 23: 329–337

    CAS  PubMed  Google Scholar 

  5. Chaleil D, Mauras Y, Allain P (1986) Oral pharmacokinetics of an enteric-coated sodium fluoride preparation. Trace Elements Medicine 3: 11–13

    CAS  Google Scholar 

  6. Chaleil D, Boulard C, Guillaume M, Allain P (1988) Etude pharmacocinétique du fluorure après une administration unique d'Ostéofluor. Thérapie 43: 5–7

    CAS  PubMed  Google Scholar 

  7. Briancon D, Quillet P, Duplan B, Chapuy MC, Arlot M, Meunier PJ (1988) Comparaison de la biodisponibilité du fluor à la suite de l'administration de fluorure de sodium seul ou en association avec du calcium. Thérapie 43: 107–110

    CAS  PubMed  Google Scholar 

  8. Mamelle N, Meunier PJ, Dusan R, Guillaume M, Martin JL, Gaucher A, Prost A, Ziegler G, Netter P (1988) Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 2: 361–365

    CAS  PubMed  Google Scholar 

  9. Riggs BL, Hodgson SF, O'Fallon WN, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 12: 802–809

    Google Scholar 

  10. Greenblatt DJ, Divol LM, Abernethy DR, Shader RI (1982) Physiologic changes in old age: relation to altered drug disposition. J Am Geriatr Soc 30: 6–10

    Google Scholar 

  11. Shand DG (1982) Biological determinants of altered pharmacokinetics in the elderly. Gerontology 28: 8–17

    CAS  PubMed  Google Scholar 

  12. Greenblatt DJ, Sellers EM, Schader RI (1982) Drug therapy: drug disposition in old age. N Engl J Med 28: 8–17

    Google Scholar 

  13. Ekstrand J, Ericsson Y, Resell S (1977) Absence of protein bound fluoride from human blood plasma. Arch Oral Biol 22: 229–232

    CAS  PubMed  Google Scholar 

  14. Whitford GM, Pashley DH, Stringer GI (1976) Fluoride renal clearance: a pH-dependent event. Am J Physiol 230: 527–532

    CAS  PubMed  Google Scholar 

  15. Hosking DJ, Chamberlain MJ (1972) Studies in man with 18 F. Clin Sci 42: 153–161

    CAS  PubMed  Google Scholar 

  16. Spencer H, Kramer L, Osis D, Wiatrowski E (1975) Excretion of retained fluoride in man. J Appl Physiol 38: 282–287

    CAS  PubMed  Google Scholar 

  17. Parsons V, Davies C, Ogg CS, Siddiquadi JY, Geode GC (1971) The ionic composition of bone from patients with chronic renal failure and on RDT with special reference to fluoride and aluminium. Proc Eur Dialysis Transplant Ass 8: 139–148

    Google Scholar 

  18. Parkins FM, Tinanoff N, Mouhinho M, Anstey MB, Waziri M (1974) Relationships of human plasma fluoride and bone fluoride to age. Calcif Tissue Res 16: 335–338

    Article  CAS  PubMed  Google Scholar 

  19. Kuo HC, Stamm JW (1975) The relationship of creatinine clearance to serum fluoride concentration and urinary fluoride excretion in man. Arch Oral Biol 20: 235–238

    CAS  PubMed  Google Scholar 

  20. Cowell DC, Taylor WH (1981) Ionic fluoride: a study of its physiological variation in man. Ann Clin Biochem 18: 76–83

    CAS  PubMed  Google Scholar 

  21. Einwag J, Trautner K (1984) Fluoridkonzentration im Serum und Fluoridausscheidung im Urin nach oraler Aufnahme von 530 mg fluorid aus NaF-Lösung. Dtsch Zahnärztl Z 39: 699–704

    CAS  PubMed  Google Scholar 

  22. Trautner K, Siebert G (1986) An experimental study of bioavailability of fluoride from dietary sources in man. Archs Oral Biol 31: 223–228

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeandel, C., Lapicque, F., Netter, P. et al. Effect of age on the disposition of sodium fluoride. Eur J Clin Pharmacol 43, 295–297 (1992). https://doi.org/10.1007/BF02333026

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02333026

Key words

Navigation